• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.

作者信息

Principi Nicola, Esposito Susanna

机构信息

Università degli Studi di Milano, Milan Italy.

Paediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, 43126 Parma, Italy.

出版信息

Lancet Infect Dis. 2020 Oct;20(10):1118. doi: 10.1016/S1473-3099(20)30296-6. Epub 2020 Apr 17.

DOI:10.1016/S1473-3099(20)30296-6
PMID:32311322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7164862/
Abstract
摘要

相似文献

1
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.氯喹或羟氯喹用于预防2019冠状病毒病。
Lancet Infect Dis. 2020 Oct;20(10):1118. doi: 10.1016/S1473-3099(20)30296-6. Epub 2020 Apr 17.
2
Hydroxychloroquine prophylaxis for COVID-19 contacts in India.印度针对新冠病毒病接触者的羟氯喹预防措施
Lancet Infect Dis. 2020 Oct;20(10):1118-1119. doi: 10.1016/S1473-3099(20)30313-3. Epub 2020 Apr 17.
3
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
4
Internet Searches for Unproven COVID-19 Therapies in the United States.互联网上对未经证实的新冠病毒治疗方法的搜索情况。
JAMA Intern Med. 2020 Aug 1;180(8):1116-1118. doi: 10.1001/jamainternmed.2020.1764.
5
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).氯喹和羟氯喹在冠状病毒病-19（COVID-19）中的预防作用的系统评价。
Int J Rheum Dis. 2020 May;23(5):613-619. doi: 10.1111/1756-185X.13842. Epub 2020 Apr 27.
6
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
7
Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.氯喹和羟氯喹的手性转换：治疗新冠肺炎的潜在药物
Drug Discov Today. 2020 Jul;25(7):1121-1123. doi: 10.1016/j.drudis.2020.04.021. Epub 2020 May 1.
8
Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?使用氯喹或羟氯喹治疗新型冠状病毒肺炎：这是否符合伦理？
Cent Eur J Public Health. 2020 Sep;28(3):246-247. doi: 10.21101/cejph.a6464.
9
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?羟氯喹啉和伊维菌素：用于新冠病毒化学预防和治疗的协同组合？
J Am Acad Dermatol. 2020 Jun;82(6):e221. doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10.
10
Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.氯喹和羟氯喹治疗新冠病毒疾病的潜力引发了系统性红斑狼疮患者对药物短缺的担忧。
Nat Med. 2020 May;26(5):632. doi: 10.1038/s41591-020-0853-0.

引用本文的文献

1
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.关于COVID-19的药物制剂、免疫疗法和支持性疗法的全面综述。
Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8.
2
Synthesis of flower-like MoS/CNTs nanocomposite as an efficient catalyst for the sonocatalytic degradation of hydroxychloroquine.花状 MoS/CNTs 纳米复合材料的合成及其作为超声催化降解羟氯喹的高效催化剂。
Ultrason Sonochem. 2022 Jun;87:106058. doi: 10.1016/j.ultsonch.2022.106058. Epub 2022 Jun 6.
3
COVID-19: A systematic review and update on prevention, diagnosis, and treatment.新型冠状病毒肺炎：预防、诊断及治疗的系统评价与更新
MedComm (2020). 2022 Feb 17;3(1):e115. doi: 10.1002/mco2.115. eCollection 2022 Mar.
4
Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection.锌增强了羟氯喹/氯喹和伊维菌素的抗病毒潜力，降低了 COVID-19 感染导致更严重后果的风险。
J Trace Elem Med Biol. 2022 May;71:126954. doi: 10.1016/j.jtemb.2022.126954. Epub 2022 Feb 17.
5
Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study.医护人员在 2019 冠状病毒病大流行期间的自我用药行为及其决定因素：横断面研究。
Int J Clin Pharm. 2022 Apr;44(2):507-516. doi: 10.1007/s11096-021-01374-4. Epub 2022 Jan 12.
6
Factors Affecting the Incidence, Progression, and Severity of COVID-19 in Type 1 Diabetes Mellitus.影响 1 型糖尿病 COVID-19 发病率、进展和严重程度的因素。
Biomed Res Int. 2021 Nov 23;2021:1676914. doi: 10.1155/2021/1676914. eCollection 2021.
7
Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective.阐述 COVID-19 对抗菌药物耐药性的影响：印度视角。
Sci Total Environ. 2022 Apr 20;818:151702. doi: 10.1016/j.scitotenv.2021.151702. Epub 2021 Nov 16.
8
Intratracheal Administration of Chloroquine-Loaded Niosomes Minimize Systemic Drug Exposure.气管内给予载氯喹脂质体可最大程度减少全身药物暴露。
Pharmaceutics. 2021 Oct 14;13(10):1677. doi: 10.3390/pharmaceutics13101677.
9
Prophylactic Medications Taken by Healthcare Workers for COVID-19; A Mixed Methods Study from South India.医护人员用于预防 COVID-19 的药物；来自印度南部的一项混合方法研究。
Int J Prev Med. 2021 Jul 29;12:90. doi: 10.4103/ijpvm.IJPVM_532_20. eCollection 2021.
10
Can closed-off management in communities alleviate the psychological anxiety and stress caused by the COVID-19 pandemic?社区封闭式管理能否缓解新冠肺炎疫情引发的心理焦虑和压力？
Int J Health Plann Manage. 2022 Jan;37(1):228-241. doi: 10.1002/hpm.3330. Epub 2021 Sep 15.

本文引用的文献

1
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.一项关于氯喹治疗 COVID-19 的疗效和安全性的系统评价。
J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
4
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases.通过氯喹类似物靶向内体酸化作为治疗新出现病毒性疾病的一种有前景的策略。
Pharmacol Res Perspect. 2017 Jan 23;5(1):e00293. doi: 10.1002/prp2.293. eCollection 2017 Feb.
5
Effects of chloroquine on viral infections: an old drug against today's diseases?氯喹对病毒感染的影响：一种治疗当今疾病的老药？
Lancet Infect Dis. 2003 Nov;3(11):722-7. doi: 10.1016/s1473-3099(03)00806-5.